Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- TBI
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseTBIControlled cortical impactC57BL/6, wildtype and FP receptor knockoutMalen = 83 male wildtype and 20 male FP receptor knockout mice in t…Intraperitoneal1 and 10 mg/kg, dissolved in dimethyl sulfoxide at 25 mg/mL…Post-injury, within ten minutes of controlled cortical impact
Model: Controlled cortical impact through a 4 mm right parietal craniotomy, impact tip 3 mm, velocity 3 m/s, compression time 100 ms, depth 1 mm; sham animals underwent craniotomy only
Controlled cortical impact produced cortical lesions of 20.0 +/- 1.0 mm3 and hippocampal swelling of 146.5 +/- 7.4 percent of contralateral. AL-8810 had no effect on cortical lesion volume at either dose but reduced hippocampal swelling to levels not different from sham, significant versus saline o…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.92. Machine-extracted fields require source verification.